Tan MH - Search Results

1

Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection.

Teo AKJ, Choudhury Y, Tan IB, Cher CY, Chew SH, Wan ZY, Cheng LTE, Oon LLE, Tan MH, Chan KS, Hsu LY. Teo AKJ, et al. Among authors: tan mh, tan ib. Sci Rep. 2021 Feb 4;11(1):3134. doi: 10.1038/s41598-021-82787-z. Sci Rep. 2021. PMID: 33542443 Free PMC article.

2

Author Correction: Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection.

Teo AKJ, Choudhury Y, Tan IB, Cher CY, Chew SH, Wan ZY, Cheng LTE, Oon LLE, Tan MH, Chan KS, Hsu LY. Teo AKJ, et al. Among authors: tan mh, tan ib. Sci Rep. 2021 Jun 9;11(1):12538. doi: 10.1038/s41598-021-89880-3. Sci Rep. 2021. PMID: 34108515 Free PMC article. No abstract available.

3

Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.

Tan R, Phua SKA, Soong YL, Oon LLE, Chan KS, Lucky SS, Mong J, Tan MH, Lim CM. Tan R, et al. Among authors: tan mh. Cancer Commun (Lond). 2020 Nov;40(11):564-585. doi: 10.1002/cac2.12100. Epub 2020 Sep 28. Cancer Commun (Lond). 2020. PMID: 32989921 Free PMC article. Review.

4

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.

Vo JH, Nei WL, Hu M, Phyo WM, Wang F, Fong KW, Tan T, Soong YL, Cheah SL, Sommat K, Low H, Ling B, Ng J, Tan WL, Chan KS, Oon L, Ying JY, Tan MH. Vo JH, et al. Among authors: tan mh, tan t, tan wl. Sci Rep. 2016 Dec 19;6(1):13. doi: 10.1038/s41598-016-0006-3. Sci Rep. 2016. PMID: 28442757 Free PMC article.

5

Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.

Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Li H, Tan HS, Kanesvaran R, Yu H, Tan MH. Choudhury Y, et al. Among authors: tan hs, tan mh. Sci Rep. 2017 Jan 25;7:41238. doi: 10.1038/srep41238. Sci Rep. 2017. PMID: 28120901 Free PMC article.

6

Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.

Chan JY, Choudhury Y, Tan MH. Chan JY, et al. Among authors: tan mh. Expert Rev Mol Diagn. 2015 May;15(5):631-46. doi: 10.1586/14737159.2015.1032261. Epub 2015 Apr 3. Expert Rev Mol Diagn. 2015. PMID: 25837857 Review.

7

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.

Wei X, Choudhury Y, Lim WK, Anema J, Kahnoski RJ, Lane B, Ludlow J, Takahashi M, Kanayama HO, Belldegrun A, Kim HL, Rogers C, Nicol D, Teh BT, Tan MH. Wei X, et al. Among authors: tan mh. Sci Rep. 2017 Aug 4;7(1):7342. doi: 10.1038/s41598-017-07191-y. Sci Rep. 2017. PMID: 28779136 Free PMC article.

8

Doubling Down on mTOR Inhibition: Harnessing ZEBRA for Insights.

Chan JY, Choudhury Y, Tan MH. Chan JY, et al. Among authors: tan mh. Eur Urol. 2016 Mar;69(3):457-9. doi: 10.1016/j.eururo.2015.09.047. Epub 2015 Oct 20. Eur Urol. 2016. PMID: 26463319 No abstract available.

9

Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres.

Wong M, Jin J, Tan MH, Lee YM, Lee TE, Ding Y, Yong HC, Lim SE, Chai LY, Chau NM, Hsu LY. Wong M, et al. Among authors: tan mh. Ann Acad Med Singap. 2012 Jul;41(7):287-93. Ann Acad Med Singap. 2012. PMID: 22892605 Free article.

10

The Issue of Tissue in Molecular Stratification.

Tan MH, Choudhury Y, Tan PH, Ng QS, Toh CK, Kanesvaran R. Tan MH, et al. Among authors: tan ph. Oncologist. 2017 Dec;22(12):1560. doi: 10.1634/theoncologist.2017-0165. Epub 2017 Sep 11. Oncologist. 2017. PMID: 28894016 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page